ImmTAV, a New Immunotherapy Targeting the Source of HBV Infection. Bertoletti A. Hepatology 2020;72:1514-1517.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bertoletti A. ImmTAV, a New Immunotherapy Targeting the Source of HBV Infection. Hepatology 2020;72:1514-1517.
PMID: 32865247